Archana Vijaya Kumar

Syndecan-1 (CD138) Modulates Triple-Negative Breast Cancer Stem Cell Properties via Regulation of LRP-6 and IL-6-Mediated STAT3 Signaling

Sherif Ibrahim, Hebatallah Hassan, Laura Vilardo et al. · PLoS ONE · 2013 · 117 citations · Full text

Medicine, Cell Biology, Oncology +17

<i>HS3ST2</i> modulates breast cancer cell invasiveness via MAP kinase‐ and Tcf4 (Tcf7l2)‐dependent regulation of protease and cadherin expression

Archana Vijaya Kumar, Ezeddin Salem Gassar, Dorothe Spillmann et al. · International Journal of Cancer · 2014 · 72 citations · Full text

Life Sciences, Molecular Biology, Oncology +16

The Heparan Sulfate Sulfotransferases HS2ST1 and HS3ST2 Are Novel Regulators of Breast Cancer Stem-Cell Properties

Felipe C. O. B. Teixeira, Archana Vijaya Kumar, Sampath Kumar Katakam et al. · Frontiers in Cell and Developmental Biology · 2020 · 36 citations · Full text

Medicine, Biochemistry, Oncology +13

HS2ST1‐dependent signaling pathways determine breast cancer cell viability, matrix interactions, and invasive behavior

Archana Vijaya Kumar, Stéphane Brézillon, Valérie Untereiner et al. · Cancer Science · 2020 · 23 citations · Full text

Life Sciences, Cell Biology, Oncology +17

Tumor suppressor miR-218 directly targets epidermal growth factor receptor (EGFR) expression in triple-negative breast cancer, sensitizing cells to irradiation

Franz-Josef Wischmann, Fabian M. Troschel, Maj Frankenberg et al. · Journal of Cancer Research and Clinical Oncology · 2023 · 18 citations · Full text

Medicine, Cell Biology, Oncology +17